Suppliers / Janssen Pharmaceutica

Janssen Pharmaceutica

Belgium Updated 9 July 2026

Janssen Pharmaceutica is an API manufacturer based in Belgium. It holds 23 valid CEPs across a filed portfolio of 20 molecules. Its filings concentrate with SFDA (Saudi Arabia), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by ANVISA (Brazil), MFDS (Korea) and NAFDAC (NG).

0
active US DMFs
23
valid CEPs
3
registered plants
84
filings across 7 regulators

Registered plants

Site FDA FEI
Beerse, United Arab Emirates Not on file
BEERSE, Belgium Not on file
Beerse, Belgium Not on file

What they file, and where

Molecule Regulators Docs
Domperidone EDQM 2
Fentanyl EDQM 2
Itraconazole EDQM 2
Loperamide EDQM, SFDA (Saudi Arabia) 2
Methylphenidate EDQM 2
Miconazole EDQM 2
Alfentanil EDQM 1
Cinnarizine EDQM 1
Econazole EDQM 1
Flubendazole EDQM 1
Show all 20 molecules on file
Flunarizine Dihydrochloride EDQM 1
Galantamine Hydrobromide EDQM 1
Haloperidol EDQM 1
Haloperidol Decanoate EDQM 1
Ketoconazole EDQM 1
Levocabastine EDQM 1
Nebivolol SFDA (Saudi Arabia) 1
Risperidone EDQM 1
Sufentanil EDQM 1
Trabectedin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
SFDA (Saudi Arabia) 28 None
ARCSA (EC) 22 None
MINSA (CR) 12 None
Health Canada 9 None
NAFDAC (NG) 9 1
EMA 2 None
ANVISA (Brazil) None 7
MFDS (Korea) None 2

Comparing suppliers?

Choose your molecules and target markets. Janssen Pharmaceutica comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates